Notably, this difference in effectiveness was observed even though fewer tirzepatide-treated patients reached higher available doses compared to semaglutide-treated patients
Under its new policy, Blue Cross Blue Shield of Massachusetts said Thursday it will continue to cover the meds, known as GLP-1s, in its standard health benefits when theyre prescribed for diabetes but not for obesity
It now has five lines of business expected to clear $100 million of revenue in 2025, with 30% of its business now coming from Hers, and the potential to expand its product offering via the Trybe acquisition
19 This research culminated in the development of dapagliflozin, canagliflozin, and empagliflozin, which were approved by the FDA between 2013 and 2014 for the treatment of T2D
Rare but serious risks exist, as with any potent pharmacological intervention
Tirzepatide Shows Powerful Diabetes-PreventionEffect in Three-Year Trial Tirzepatide Shows Powerful Diabetes-Prevention Effect in Three-Year Trial The landscape of diabetes prevention and obesity treatment has taken a revolutionary turn with groundbreaking three-year clinical trial results for Tirzepatide